@article{d4c35ef41505479cb438a91ca09e9500,
title = "Sustained remission in patients with treatment-resistant depression receiving vagal nerve stimulation: A case series",
keywords = "Major depressive disorder, Treatment-resistant depression, Vagus nerve stimulation",
author = "Salloum, \{Naji C.\} and Gott, \{Britt M.\} and Conway, \{Charles R.\}",
note = "Funding Information: The registry studies were sponsored by Cyberonics, Inc., makers of the VNS device. Dr. Conway has received research support from Bristol-Myers Squibb, the Stanley Medical Research Institute (14T-010), the National Institute of Mental Health (K08 Award 1K08MH078156-01A1 and R21 Award 1R21MH108901-01A1), NeoSync, Inc., Brain \& Behavior Research Foundation, McDonnell Center for Systems Neuroscience, Cyberonics, Inc., (all not related to the subject matter of the paper); The Taylor Family Institute for Innovative Psychiatric Research, The August Busch IV Foundation, and Barnes-Jewish Hospital Foundation. He has served as an unpaid consultant to Cyberonics, Inc. Other authors report no research funding.",
year = "2017",
month = sep,
doi = "10.1016/j.brs.2017.06.001",
language = "English",
volume = "10",
pages = "997--1000",
journal = "Brain Stimulation",
issn = "1935-861X",
number = "5",
}